Initiated Buy X

BLFS BioLife Solutions

H.C. Wainwright

$29

Initiated Buy X

BLFS BioLife Solutions

Jefferies

$22

Initiated Buy X

BLFS BioLife Solutions

Craig Hallum

$29

Upgrades Perform Outperform X

BLFS BioLife Solutions

Oppenheimer

$28

Initiated Buy X

BLFS BioLife Solutions

B. Riley Securities

$61

Resumed Outperform X

BLFS BioLife Solutions

Cowen

$64

Downgrades Buy Hold X

BLFS BioLife Solutions

The Benchmark Company

Upgrades Hold Buy X

BLFS BioLife Solutions

The Benchmark Company

$54

Initiated Buy X

BLFS BioLife Solutions

H.C. Wainwright

$23

BLFS  BioLife Solutions, Inc.

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.